 |
市場調查報告書
商品編碼
1983137
假尿苷市場：按產品類型、純度、劑型、應用、最終用戶、包裝規格、分銷管道和地區分類Pseudouridine Market, By Product Type , By Purity, By Form, By Application, By End User, By Pack Size, By Distribution Channel, By Geography |
||||||
預計到 2026 年，假尿苷市值將達到 3,990 萬美元，到 2033 年將達到 5,470 萬美元。預計從 2026 年到 2033 年，其複合年成長率將達到 4.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 3990萬美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 4.60% | 2033年市場規模預測： | 5470萬美元 |
全球假尿苷市場是醫藥和生物技術產業中一個快速發展的領域，這主要得益於該化合物在RNA修飾和治療應用中的關鍵作用。假尿苷常被稱為“第五種核苷”，是一種天然存在的修飾核苷，在細胞過程中發揮著至關重要的作用，尤其是在核醣體RNA和轉移RNA的穩定性和功能方面。近年來，由於其在mRNA疫苗技術中的關鍵作用，這種尿苷異構體引起了廣泛關注。尤其是在新冠疫情爆發以來，假尿苷修飾促進了高效mRNA疫苗的研發。
除了在疫苗領域的應用外，假尿苷在基因治療、癌症治療以及其他對RNA穩定性和免疫逃脫要求極高的治療性介入中也展現出巨大的潛力。該市場涵蓋多種形式，例如合成假尿苷、修飾的假尿苷衍生物和含假尿苷的寡核苷酸，這些產品被研究機構、製藥公司和生物技術公司廣泛使用。隨著我們對RNA生物學認知的不斷深入以及對創新治療方法需求的成長，在持續的研究舉措、監管核准以及個性化醫療和先進治療平台中不斷擴展的應用的推動下，假尿苷市場預計將顯著成長。
市場動態
全球假尿苷市場的主要驅動力是mRNA疫苗技術的空前成功和廣泛應用。這項技術已證明假尿苷修飾在實現治療效果和安全性方面至關重要。新冠疫情刺激了對基於mRNA的療法的巨額投資，從而產生了對高品質假尿苷化合物的巨大需求，並推動了市場擴張。此外，基因治療、癌症免疫療法和基於RNA的藥物遞送系統等領域研究活動的活性化也促進了市場成長。這是因為假尿苷修飾可以增強RNA穩定性、降低免疫抗原性並改善治療效果。
慢性病盛行率的上升以及對個人化醫療需求的日益成長，進一步推動了市場發展，製藥公司正積極探索標靶治療的創新解決方案。然而，該市場也面臨著許多限制因素，例如複雜的生產流程需要專業知識和先進設備，導致生產成本飆升和供應商數量有限。 RNA療法相關的監管複雜性以及對藥用級假尿苷的嚴格品質要求，進一步阻礙了市場准入和擴張。此外，智慧財產權方面的挑戰和專利問題也可能限制部分製造商的市場准入。
儘管有這些局限性，但在蛋白質替代療法、組織工程和再生醫學等新興應用領域，假尿苷修飾的RNA仍蘊藏著巨大的機遇，有望展現出更優的治療效果。隨著RNA療法在各個治療領域的不斷湧現，以及生產技術的進步和研發經費的增加，為那些尋求掌握分子醫學發展趨勢的市場參與企業提供了廣闊的成長空間。
本次調查的主要特點。
- 本報告對全球假尿苷市場進行了詳細分析，以 2025 年為基準年，給出了預測期（2026-2033 年）的市場規模和複合年成長率（%）。
- 本報告指出了各個細分市場的潛在商機，並說明了該市場中一系列有吸引力的投資提案。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
- 本報告根據以下參數對全球假尿苷市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用全球假尿苷市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 研究目標
- 前提
- 簡稱
第2章 市場範圍
- 報告摘要
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 法規環境
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 法規環境
- 主要進展
- 產業趨勢
第4章 全球假尿苷市場：依產品類型（化學性質）分類，2021-2033年
- 假尿苷
- N1-甲基吡咯尿苷
第5章 全球假尿苷市場：依純度分類，2021-2033年
- 研究級（RUO）
- GMP/臨床級
- 商業/API級
第6章 全球假尿苷市場：依形態分類，2021-2033年
- 粉末（凍乾/結晶質）
- 溶液（水溶液/緩衝液）
第7章 全球假尿苷市場：依應用領域分類，2021-2033年
- mRNA治療藥物（人類使用）
- mRNA疫苗（人類使用）
- mRNA動物用藥品（疫苗/治療藥物）
- 寡核苷酸/RNA 工具（對照品、標準品、探針）
- 細胞與基因治療研究（RNA工程工作流程）
- 診斷與檢測（基於RNA的試劑盒、校正材料）
第8章 全球假尿苷市場：依最終用戶分類，2021-2033年
- 製藥和生物製藥公司
- CDMO/CMO（RNA合成、LNP製備、填充/精加工）
- CRO（臨床前/臨床支援實驗室）
- 學術和研究機構
- 政府和公共衛生研究機構
- 診斷藥物生產商
第9章 全球假尿苷市場：依包裝規格分類，2021-2033年
- 微量（100毫克或更少）
- 小劑量（100毫克-1克）
- 中（1-25克）
- 散裝（25克）
第10章 全球假尿苷市場：依通路分類，2021-2033年
- 線上
- 離線
第11章 全球假尿苷市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第12章 競爭格局
- TriLink BioTechnologies
- Yamasa Corporation Biochemicals Division
- Hongene Biotech
- Roche CustomBiotech
- Thermo Fisher Scientific
- Biosynth
- Jena Bioscience
- Yeasen Biotechnology
- ULCHO Biochemical
- Glycogene
- Shanghai AECOM Biotechnology
- Tianjin Scaxchem
- Wuhu Huaren Science and Technology
- Jinan Carbotang Biotech
- Hangzhou TCM Biotech
第13章 分析師建議
- 機會
- 分析師意見
- Coherent Opportunity Map
第14章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
Pseudouridine Market is estimated to be valued at USD 39.9 Mn in 2026 and is expected to reach USD 54.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 39.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.60% | 2033 Value Projection: | USD 54.7 Mn |
The global pseudouridine market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, driven by the compound's critical role in RNA modifications and therapeutic applications. Pseudouridine, often referred to as the fifth nucleoside, is a naturally occurring modified nucleoside that plays essential functions in cellular processes, particularly in ribosomal RNA and transfer RNA stability and function. This isomer of uridine has gained significant attention in recent years due to its pivotal role in mRNA vaccine technology, particularly following the COVID-19 pandemic, where pseudouridine modifications enabled the development of highly effective mRNA vaccines.
Beyond vaccine applications, pseudouridine demonstrates promising potential in gene therapy, cancer treatment, and various therapeutic interventions where RNA stability and immune evasion are crucial. The market encompasses various forms including synthetic pseudouridine, modified pseudouridine derivatives, and pseudouridine-containing oligonucleotides used across research institutions, pharmaceutical companies, and biotechnology firms. As the understanding of RNA biology advances and the demand for innovative therapeutic modalities increases, the pseudouridine market is positioned for substantial growth, supported by ongoing research initiatives, regulatory approvals, and expanding applications in personalized medicine and advanced therapeutic platforms.
Market Dynamics
The global pseudouridine market is primarily driven by the unprecedented success and widespread adoption of mRNA vaccine technology, which has demonstrated the critical importance of pseudouridine modifications in achieving therapeutic efficacy and safety. The COVID-19 pandemic catalyzed massive investments in mRNA-based therapeutics, creating substantial demand for high-quality pseudouridine compounds and driving market expansion. Additionally, growing research activities in gene therapy, cancer immunotherapy, and RNA-based drug delivery systems are fueling market growth, as pseudouridine modifications enhance RNA stability, reduce immunogenicity, and improve therapeutic outcomes.
The increasing prevalence of chronic diseases and the need for personalized medicine approaches further contribute to market drivers, as pharmaceutical companies seek innovative solutions for targeted therapies. However, the market faces significant restraints including complex manufacturing processes that require specialized expertise and sophisticated equipment, leading to high production costs and limited supplier base. Regulatory complexities surrounding RNA-based therapeutics and the stringent quality requirements for pharmaceutical-grade pseudouridine create additional barriers for market entry and expansion. Furthermore, intellectual property challenges and patent landscapes may restrict market accessibility for some manufacturers.
Despite these constraints, substantial opportunities exist in emerging applications such as protein replacement therapies, tissue engineering, and regenerative medicine, where pseudouridine-modified RNAs can provide superior therapeutic benefits. The expanding pipeline of RNA-based therapeutics across various therapeutic areas, coupled with advancing manufacturing technologies and increasing research funding, presents lucrative growth prospects for market participants seeking to capitalize on the evolving landscape of molecular medicine.
Key Features of the Study
- This report provides in-depth analysis of the global pseudouridine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pseudouridine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include TriLink BioTechnologies, Yamasa Corporation Biochemicals Division, Hongene Biotech, Roche CustomBiotech, Thermo Fisher Scientific, Biosynth, Jena Bioscience, Yeasen Biotechnology, ULCHO Biochemical, Glycogene, Shanghai AECOM Biotechnology, Tianjin Scaxchem, Wuhu Huaren Science and Technology, Jinan Carbotang Biotech, and Hangzhou TCM Biotech
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pseudouridine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pseudouridine market
Market Segmentation
- Product Type (chemistry) Insights (Revenue, USD Mn, 2021 - 2033)
- Pseudouridine
- N1-methylpseudouridine
- Purity Insights (Revenue, USD Mn, 2021 - 2033)
- Research Grade (RUO)
- GMP / Clinical Grade
- Commercial / API Grade
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Powder (lyophilized / crystalline)
- Solution (aqueous / buffered)
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- mRNA Therapeutics (human)
- mRNA Vaccines (human)
- mRNA Veterinary (vaccines / therapeutics)
- Oligonucleotide / RNA Tools (controls, standards, probes)
- Cell & Gene Therapy Research (RNA engineering workflows)
- Diagnostics & Assays (RNA-based kits, calibration materials)
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharma & Biopharma Companies
- CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish)
- CROs (preclinical/clinical support labs)
- Academic & Research Institutes
- Government / Public Health Labs
- Diagnostic Companies
- Pack Size Insights (Revenue, USD Mn, 2021 - 2033)
- Micro (<=100 mg)
- Small (100 mg-1 g)
- Medium (1-25 g)
- Bulk (25 g)
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- TriLink BioTechnologies
- Yamasa Corporation Biochemicals Division
- Hongene Biotech
- Roche CustomBiotech
- Thermo Fisher Scientific
- Biosynth
- Jena Bioscience
- Yeasen Biotechnology
- ULCHO Biochemical
- Glycogene
- Shanghai AECOM Biotechnology
- Tianjin Scaxchem
- Wuhu Huaren Science and Technology
- Jinan Carbotang Biotech
- Hangzhou TCM Biotech
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Pseudouridine Market, By Product Type (Chemistry)
- Global Pseudouridine Market, By Purity
- Global Pseudouridine Market, By Form
- Global Pseudouridine Market, By Application
- Global Pseudouridine Market, By End User
- Global Pseudouridine Market, By Pack Size
- Global Pseudouridine Market, By Distribution Channel
- Global Pseudouridine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Pseudouridine Market, By Product Type (Chemistry), 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pseudouridine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- N1-methylpseudouridine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Pseudouridine Market, By Purity, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Research Grade (RUO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- GMP / Clinical Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Commercial / API Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Pseudouridine Market, By Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Powder (lyophilized / crystalline)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Solution (aqueous / buffered)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Pseudouridine Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- mRNA Therapeutics (human)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- mRNA Vaccines (human)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- mRNA Veterinary (vaccines / therapeutics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oligonucleotide / RNA Tools (controls, standards, probes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cell & Gene Therapy Research (RNA engineering workflows)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostics & Assays (RNA-based kits, calibration materials)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Pseudouridine Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharma & Biopharma Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CROs (preclinical/clinical support labs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Government / Public Health Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Pseudouridine Market, By Pack Size, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Micro (<=100 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Small (100 mg-1 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medium (1-25 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Bulk (25 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Pseudouridine Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global Pseudouridine Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- TriLink BioTechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yamasa Corporation Biochemicals Division
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hongene Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche CustomBiotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biosynth
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jena Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yeasen Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ULCHO Biochemical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glycogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai AECOM Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tianjin Scaxchem
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wuhu Huaren Science and Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jinan Carbotang Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hangzhou TCM Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
RNAi藥物遞送市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、最終用戶、材料類型、製程、階段分類
全球RNA療法市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
RNA合成市場依產品類型、技術、應用、規模和最終用戶分類，全球預測（2026-2032年）基於 GalNAc 的藥物市場（按產品類型、適應症、給藥途徑、臨床試驗階段和最終用戶分類），全球預測，2026-2032 年
RNA編輯技術市場－全球產業規模、佔有率、趨勢、機會和預測，按RNA類型、應用、技術、地區和競爭格局分類，2020-2030年預測RNA 針對小分子藥物研發市場－全球產業規模、佔有率、趨勢、機會及預測（按適應症、最終用戶、地區和競爭細分，2020-2030 年）
RNA靶向小分子藥物發現市場規模、佔有率、趨勢分析報告：按適應症、最終用途、地區、分部預測、分部預測，2025-2030年
日本 RNA 療法市場評估：依類型、產品、適應症、最終用戶、地區、機會和預測（2018年度-2032年度）RNA治療印度市場評估：依類型、依產品、依適應症、依最終用戶、依地區、機會、預測（2018年度-2032年度）美國的RNA治療藥市場評估:類型·產品·適應症·終端用戶·各地區的機會及預測 (2017-2031年)